The PSD-95 inhibitor also had a favorable safety profile in phase III trial ...

An investigational anti-clotting medication, asundexian, has demonstrated a reduction in the risk of a second ischemic ...

An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic ...

Late-Breaking Science Abstract LB 032 - In a phase III clinical trial in China, stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days starting ...

Strokes are more severe and deadly among COVID-19 patients than among people without the disease, a new study shows. The study, published in the journal Stroke, examined 3,556 patients who were being ...

(CNN) — It’s second nature for some people to pour a glass of wine on a nice evening or to pop open a can of beer during a sports event — but when does drinking become too much? Heavy alcohol use, ...

People are understandably concerned when health conditions or infectious diseases that were once well-managed start increasing again, but proper education and advancements in medicine mean we often ...

Traditional stroke rehabilitation therapy focuses on restoring strength and movement to the more impaired side of the body, ...

Rehabilitation from stroke has traditionally focused on improving the function of the most severely affected arm. But ...

Left atrial appendage closure was associated with about half as many disabling or fatal strokes and lower mortality after a stroke compared with dual oral anticoagulant therapy in patients with atrial ...